Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hyaluronan-oxime hydrogel is a synthetic biomaterial formed by the crosslinking of modified hyaluronic acid (HA) chains through oxime chemistry, typically involving the reaction between an aldehyde or ketone group and a hydroxylamine group. It is not a biological target (such as a receptor or enzyme) but rather a versatile drug delivery system and tissue engineering scaffold. The oxime linkage is particularly valued in biomedical applications due to its hydrolytic stability, biocompatibility, and the fact that the reaction can occur under physiological conditions without the need for toxic catalysts. In therapeutic contexts, these hydrogels are used to provide a sustained release of drugs, proteins, or cells directly to a site of interest, such as an osteoarthritic joint or a surgical wound. Because hyaluronan is a primary component of the natural extracellular matrix, these hydrogels exhibit excellent integration with host tissues and can be enzymatically degraded by hyaluronidases.
Not applicable as a target; functions as a drug delivery vehicle or scaffold via controlled degradation and release of encapsulated therapeutic agents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hyaluronan-oxime hydrogel (HA-oxime hydrogel).